RegenMed   Report issue

Academic/Hospital Phase 2
Founded: Menlo Park CA United States (2010)

Organization Overview

First Clinical Trial
2016
NCT02525263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now